4N90 | Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Huang, X. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.30 | ||||||||||||
ligand | ZN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity., Graves JD, Kordich JJ, Huang TH, Piasecki J, Bush TL, Sullivan T, Foltz IN, Chang W, Douangpanya H, Dang T, O'Neill JW, Mallari R, Zhao X, Branstetter DG, Rossi JM, Long AM, Huang X, Holland PM, Cancer Cell. 2014 Aug 11;26(2):177-89. doi: 10.1016/j.ccr.2014.04.028. Epub 2014 , Jul 17. PMID:25043603 |
Data retrieval |
View 4N90 in 3D |
Visual 3D analysis of 4N90 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4N90 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |